Blood Loss and Saline Infusion for Dehydration

N/A

Waitlist Available

Research Sponsored by Zynex Monitoring Solutions

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 - 36 hours

Awards & highlights

Study Summary

This trial tests if a medical device helps reduce blood loss during surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 - 36 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 - 36 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 - 36 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Specificity and sensitivity of minor blood loss detection and saline reinfusion

Trial Design

1Treatment groups

Experimental Treatment

Group I: Blood Loss and Saline InfusionExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CM-1600

2023

N/A

~380

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Zynex Monitoring SolutionsLead Sponsor

8 Previous Clinical Trials

841 Total Patients Enrolled

~9 spots leftby May 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.